Frontal white matter hyperintensity volume

Biomarker

2 papers3 findings

  • Human trial1
  • Humans1

Associations

3

Apathy improvement

downin humans1

1 study
  1. Frontal white matter hyperintensity volume is associated with apathy improvement in humans (Interaction β = 0.186, SE = 0.076; FDR-adjusted p = 0.048).

    “This effect was driven by improvements in apathy (frontal: β = 0.186, SE = 0.076, FDR-adjusted p = 0.048;”

    Human trialVascular mild cognitive impairment; response to acetylcysteine plus exercise; lower baseline volume associated with greater improvementbrain2400 mg daily acetylcysteine6 months

    Brain scan findings linked to symptom relief in memory trial

    Journal of Alzheimer's disease : JAD7 Oct 2026

Neuropsychiatric symptom improvement

downin humans1

1 study
  1. Frontal white matter hyperintensity volume is associated with neuropsychiatric symptom improvement in humans (Interaction β = 0.229, SE = 0.070; FDR-adjusted p = 0.007).

    “Lower baseline frontal (β = 0.229, SE = 0.070, FDR-adjusted p = 0.007) and global”

    Human trialVascular mild cognitive impairment; response to acetylcysteine plus exercise; lower baseline volume associated with greater improvementbrain2400 mg daily acetylcysteine6 months

    Brain scan findings linked to symptom relief in memory trial

    Journal of Alzheimer's disease : JAD7 Oct 2026

Neuropsychiatric symptoms

upin humans1

1 study
  1. Neuropsychiatric symptoms are associated with frontal white matter hyperintensity volume in humans.

    “several associations, particularly with WMH volume, were found in males, but not in females”

    Humansin cognitively unimpaired older adultsmales

    Sex‐specific effects of neuropsychiatric symptoms on amyloid and tau pathology and white matter hyperintensity volume in preclinical Alzheimer's disease

    AAIC 2025 abstract24 Dec 2025

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 12 in 12 months
Journal of Alzheimer's Disease

Brain scan findings linked to symptom relief in memory trial

In a six-month trial of 51 people with vascular mild cognitive impairment, lower volumes of bright brain areas were linked to greater symptom reductions.In a six-month trial of 51 people with vascular mild cognitive impairment, lower volumes of bright brain areas were linked to greater symptom reductions.

Randomised trial in peopleInterventions